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ABSTRACT The HIV-1 integrase, which is essential for viral replication, catalyzes the insertion of viral DNA into the host
chromosome, thereby recruiting host cell machinery into making viral proteins. It represents the third main HIV enzyme target
for inhibitor design, the first two being the reverse transcriptase and the protease. Two 1-ns molecular dynamics simulations
have been carried out on completely hydrated models of the HIV-1 integrase catalytic domain, one with no metal ions and
another with one magnesium ion in the catalytic site. The simulations predict that the region of the active site that is missing
in the published crystal structures has (at the time of this work) more secondary structure than previously thought. The
flexibility of this region has been discussed with respect to the mechanistic function of the enzyme. The results of these
simulations will be used as part of inhibitor design projects directed against the catalytic domain of the enzyme.
INTRODUCTION
The human immunodeficiency virus type 1 (HIV-1) en-
codes three enzymes as part of the POL gene, namely the
reverse transcriptase (RT), protease (PR), and integrase
(IN). Drugs have been available for a number of years that
target the RT and several have recently been approved that
operate against the PR. In fact, cocktails of these com-
pounds have proven to be quite effective in the clinical
applications. However, in part based on problems of patient
noncompliance, resistant strains are known which render
each of these drugs ineffective. It has therefore become
imperative that drugs be designed to target other aspects of
the viral life cycle and that they be designed in such a way
as to make them less prone to resistance (escape) mutations.
One recent target is the HIV-1 integrase, for which a mostly
complete crystal structure of the catalytic domain was pub-
lished in 1994 (1ITG) (Dyda et al., 1994). A second crystal
structure was published in 1996 (2ITG) which contains all
residues missing in the active site from the first structure
(Bujacz et al., 1996a); however, they form a rather extended
conformation and have moderately high thermal factors.
The HIV-1 integrase is composed of a single polypeptide
chain that folds into three functional domains (Fig. 1) (An-
drake and Skalka, 1996). Three-dimensional structures have
been determined for all three domains separately and all
form dimers. The N-terminal domain is comprised of resi-
dues 1–50 and has a zinc binding motif that is different
from the typical zinc finger fold, based on NMR studies
(Cai et al., 1997; Eijkelenboom et al., 1997), and is known
to be important for protein-protein multimerization (Zheng
et al., 1996; Lee et al., 1997; Heuer and Brown, 1998). The
C-terminal domain, residues 212–288, takes on an SH3-
type fold (Lodi et al., 1995; Lutzke and Plasterk, 1998;
Eijkelenboom et al., 1995) and is known to bind DNA
strongly but nonspecifically (Lutzke and Plasterk, 1998;
Khan et al., 1991; Vink et al., 1993; Woerner and Marcus-
Secura, 1993; Lutzke et al., 1994; Engelman et al., 1994).
All three domains are required for full catalytic activity
(Vink et al., 1993; Drelich et al., 1992; Schauer and Billich,
1992), although the purified catalytic domain can carry out
a so-called disintegration reaction (Chow et al., 1992; Bush-
man et al., 1993).
The catalytic domain, which is composed of residues
50–212, has an RNaseH-type fold and belongs to the su-
perfamily of polynucleotidyl transferases. The active site is
comprised of two Asp residues and one Glu, in the typical
D,D(35)E motif, each of which is required for catalysis
(Engelman and Cragie, 1992; Kulkosky et al., 1992; van
Gent et al., 1993). It has fairly low sequence homology with
the avian sarcoma virus (ASV) integrase (24% identity);
however, they share very high structural homology, espe-
cially in the catalytic region (Bujacz et al., 1995). The
enzyme carries out at least two reactions, namely 3 pro-
cessing and strand transfer.
In the 3-processing reaction, the integrase cleaves a
dinucleotide from both 3 ends of viral DNA adjacent to the
highly conserved CA dinucleotide, in the long terminal
repeat (LTR) region (Rice et al., 1996; Pommier et al.,
1997). The newly exposed 3 hydroxyl groups then undergo
a concerted transesterification strand transfer reaction
across a five-basepair stretch in the host DNA, such that the
viral DNA is now inserted into the host chromosome. (Rice
et al., 1996; Pommier et al., 1997) This results in a dangling
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5 dinucleotide at each end of the integration along with a
five-basepair repeat at each end. These regions are presum-
ably repaired by host DNA repair enzymes, although it is
possible that the integrase may be involved in some aspects
of the repair. The catalytic domain of the integrase, as
mentioned above, can also carry out another reaction,
known as disintegration (Chow et al., 1992; Bushman et al.,
1993). This reaction is commonly used to assay for efficacy
of inhibitors directed against the catalytic domain and is
essentially the reverse of the strand transfer reaction.
Crystal structures are available for the catalytic core
domain of the HIV-1 integrase, but each structure has miss-
ing or poorly defined regions near the active site. (Dyda et
al., 1994; Bujacz et al., 1996a) Although divalent ions are
known to bind within the active site, none were detected in
the crystal structures (Dyda et al., 1994; Bujacz et al.,
1996a). In an effort to describe the active site and address
the binding of metal ions in the catalytic domain, we have
performed crystallographic structure determinations and
computer simulations. Throughout our exploratory molecu-
lar dynamics (MD) simulations, we observed important
conformational interactions in the active region, particularly
residues 141–150, which are part of the unsolved region in
the crystal structures. The presence of a divalent metal in the
active site, the conformations of Q148 and Y143, and sec-
ondary structure transitions constitute the salient points of
our studies providing, for the first time, information about
the dynamic behavior of the HIV-1 integrase catalytic do-
main. Furthermore, descriptions of the hydrated active site
are provided which should prove useful in drug design as it
provides a model for the uncomplexed active site in vivo.
METHODOLOGY
Crystallization and structure determination
The catalytic domain (residues 50–212) of the HIV-1 integrase containing
a single mutation (F185K) was expressed and purified according to the
published method (Dyda et al., 1994). The protein crystals were obtained
by vapor diffusion at 277 K using 15 mM ammonium sulfate and 5 mM
dithiothreitol, as a precipitant. This condition is similar to what has been
published by Dyda et al. (1994). The integrase crystallized in the space
group P3121 with unit cell dimensions a b 7.26, c 6.55 nm. In order
to collect the x-ray diffraction data, crystals were equilibrated in cryopro-
tectant prior to freezing by a nitrogen stream at 110 K.
Diffraction data for the present study were collected to 0.18 nm reso-
lution at the 1–5 beamline at the Stanford Synchrotron Radiation Labora-
tory. To obtain the set of phases, rigid-body refinement was performed
using the 1ITG structure coordinates as the starting model and with use of
the X-Plor computer program (Brunger, 1996). Subsequent rounds of
positional and temperature factor refinement were performed alternating
with manual inspection of 2Fo-Fc electron density maps.
Modeling
This structure contained residues 57–140, 149–189, 193–210 in addition to
110 crystal waters. The missing regions (141–148, 190–192) were com-
pleted in order to perform MD simulations. A model of the first missing
region (141–148) was generated from a backbone alignment against an
ASV integrase structure (1ASV) (Bujacz et al., 1995), while the second
missing region (190–192) was modeled based on an alignment with a
previous HIV-1 integrase structure determined as described above. The
primary sequence in this missing region was corrected using the residue
replacement feature in the InsightII software (InsightII, 1997), because the
HIV and ASV integrases do not have the same amino acid sequence
(IPYNPQSQ for HIV and IPGNSQGQ for ASV).
The ionization state for each ionizable residue in the catalytic domain
was predicted using a procedure available in the UHBD program (Madura
et al., 1995), which is used to perform a detailed electrostatics analysis of
the protein employing a continuum dielectric treatment of the solvent
(Antosiewicz et al., 1994, 1996a, b). Effects of ionic strength can also be
treated with this method, although an ionic strength of 0 was used in the
present study. No unusual amino acid ionization states were predicted.
Hydrogens were then added to the protein and crystal water molecules
using the HBUILD module in CHARMM v.25 (HBUILD, 1992) based on
the predicted ionization state for each residue. In the case of the simulation
involving one Mg2, the metal was placed between the first two catalytic
residues (D64 and D116) in the same relative position where it is observed
in an ASV structure (1ASH) (Bujacz et al., 1996b). One or more counte-
rions were added such that they were not initially within 1.0 nm of any
protein atom. The system (protein, crystal waters, counterions, and Mg2),
which has a maximum dimension of 4.0 nm, was embedded in a 6.4 
6.4  6.4 nm box of water. Water molecules that were found to be within
0.28 nm of any atom in the solute were removed, resulting in 2375 solute
atoms and 23,187 solvent atoms for the simulation without a metal ion. The
simulation with one Mg2 also required the addition of two Cl ions and
had a system size of 2378 solute atoms and 23,064 solvent atoms. The
SPC/E water model (Berendsen et al., 1987) was used to describe the
solvent. A 1.0 nm short-range cutoff was used for all nonbonded interac-
tions, and long-range electrostatic interactions were treated by the PME
method (Essmann et al., 1995), with a grid size of 64 64 64 (i.e., there
is no neglect of any electrostatic interactions). No correction was applied
for the neglected long-range van der Waals interactions because they are
expected to be small.
Molecular dynamics
The simulation system was equilibrated, as described below, in a stepwise
fashion in order to eliminate bad atomic contacts in a gradual way. The
solvent was energy-minimized, keeping the protein and counterions/Mg2
fixed, using 200 steps of steepest descent, plus an additional 200 steps for
the whole system. Solvent equilibration (protein  counter ions/Mg2
fixed) was carried out by performing molecular dynamics for 20 ps at 298
K using a 1-fs time step. Equilibration of the solute (solvent fixed) was
performed for 5 ps each at temperature intervals of 50, 100, 150, 200, 250,
and 298 K with velocity reassignment every 0.5 ps and a time step of 2 fs.
Finally, the whole system (solute and solvent) was equilibrated for 10 ps at
298 K using a 2-fs time step. Periodic boundary conditions, SHAKE
(Ryckaert et al., 1977), and the NVT ensemble were used throughout the
minimization/equilibration procedure.
FIGURE 1 Schematic of the structure and function of the various do-
mains of the HIV-1 integrase.
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Data acquisition was carried out for 1 ns at 298 K with separate
relaxation times for the solvent and solute of 0.4 and 0.1 ps, respectively,
using periodic boundary conditions in the NPT ensemble (pressure 
1.025  105 Pa). A SHAKE (Ryckaert et al., 1977) tolerance of 104 nm
was applied to all bonds involving a hydrogen atom. A 2-fs time step was
used and snapshots of the trajectory were taken every 0.1 ps (50 time
steps).
All energy/MD calculations were performed using the AMBER95 force
field (Cornell et al., 1995) and the leapfrog time step algorithm as imple-
mented in the parallel NWChem v3.2 program (Anchell et al., 1998).
Calculations were performed on IBM SP2 and Cray T3E parallel comput-
ers at SDSC and the University of Texas, respectively, using a spacial
decomposition of the molecular system across processors. The physical
volume was divided into rectangular boxes, each of which was sent to a
processor that handled one or more units of these grouped boxes. The
efficiency of the NWChem program (Anchell et al., 1998) was improved
with the use of methods that minimize the number of solute-bonded
interactions crossing node boundaries, by avoiding solvent bonded inter-
actions between nodes, and by breaking the molecular system into sepa-
rately treated solvent and solute parts (Anchell et al., 1998). Also, algo-
rithms allowing dynamic balancing of the workload and which manage the
communication calls between the processors were used to this aim (An-
chell et al., 1998). The AMBER potential energy function (Cornell et al.,
1995) used is given by,
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The first three terms describe the bonded interactions, while the fourth term
accounts for the nonbonded ones. The bonded terms are described by
harmonic potentials for bond stretching (first term), angle bending (second
term), and dihedral bending (third term). The nonbonded interactions are
represented by the fourth term where the Lennard-Jones potential function
describes the van der Waals interactions and the electrostatic term is given
by a Coulombic function based on the separation of atom-centered point
charges.
RESULTS AND DISCUSSION
Crystal structure
The starting structure coordinates for the molecular dynam-
ics simulations are the result of crystallographic refinement
and manual rebuilding using data at a significantly higher
resolution; several notable changes were made to the start-
ing model (Dyda et al., 1994). The side chains with the most
significant differences from the starting model were those of
His-67, Val-77, Phe-83, Ile-84, Glu-85, Arg-107, Phe-121,
Lys-136, Phe-139, Lys-186, and Tyr-194. In addition to
these changes, the most notable is in the backbone confor-
mation within the region (residues 140–153) that has been
previously ambiguous (Dyda et al., 1994). This region of the
polypeptide chain contains the catalytic residue E152. In the
present structure, residues from 148 to 153 are clearly
defined in helical conformations, which is in contrast to
what has been proposed and modeled in the structure of
HIV-1 IN (F185H; 2ITG) (Bujacz et al., 1996a), but is close
to the conformation of ASV IN (Bujacz et al., 1995)
(Fig. 2).
Two systems involving the HIV-1 integrase catalytic
domain were treated here, one with no metal in the active
site region and a second containing one Mg2 ion placed
between the first two catalytic residues (D64, D116), based
on alignments with crystal structures of the ASV integrase.
Molecular properties and dynamical stability
No metal in the active site
Analysis of molecular properties can provide some insight
into how stable various parts of the molecular system are
FIGURE 2 Superposition of the backbone conformations of ASV (thin line) and the HIV-1 (thick line) IN crystal structure reported herein.
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with time. After a total of only 60 ps of equilibration, as
described earlier, the temperature of the solute and solvent,
total potential energy, and nonbonded intrasolute and sol-
ute-solvent interactions (Fig. 3), were observed to be quite
constant across the 1 ns of data collection, meaning that the
system was well-equilibrated. The mean temperature for the
solute was 298.29  1.05 K and for the solvent 297.96 
0.70 K.
The root-mean-squared deviations (RMSD) of all protein
atoms were calculated using the What If program (Vriend,
1990) over the 1-ns trajectory taking as a reference frame
the average structure (Fig. 4). The time evolution of the
RMSD with respect to the average structure provides a
measurement of the convergence of the dynamical proper-
ties of the protein. Each frame of the trajectory was super-
imposed on the reference frame using a least-squares fit
method; periodicity effects, rotational, and translational mo-
tion were removed, leaving just the internal motions of the
system. The RMSD from the average structure is stable after
400 ps, showing that our MD was successfully converged to
an RMSD of 0.06–0.1 nm, even though two parts of the
structure were model-built (a total of 11 residues). These
regions and their neighborhood exhibit high flexibility, pos-
sibly explaining why their 3D structures could not be well
determined by x-ray techniques. However, this result also
indicates that those regions converged reasonably well, with
respect to the starting structure, after 400 ps. In Fig. 5, a
comparison between the C	 x-ray B-factors and the atomic
fluctuations over 1 ns of MD simulation are shown. Note
that the areas with the highest flexibility in our simulation
are in excellent agreement with the regions that have the
largest B-factors in the x-ray structure.
One metal in active site
The same analyses were performed for the HIV-1 integrase
containing one metal in the active site, which was placed
between the D64 and D116 residues based on alignments
with the ASV integrase, as described above. All of the
physical and chemical properties mentioned above were
quite well-equilibrated, as in the system containing no
FIGURE 3 Time dependence of temperature (top graph) of the solvent
(Œ) and solute (E); total potential energy (middle graph); and solute-solute
nonbonded interactions (bottom graph, F) and nonbonded solute-solvent
interactions ({) for the no-metal simulation. All plots are shown as 10 ps
averages. The uptick in the bottom panel at 400 ps was caused by a
rearrangement of the solvent with respect to the protein due to a secondary
structure transition (coil to helix) in the region 145–149. Note that after 500
ps this energy is again stabilized. This transition is well illustrated in Fig.
7, top.
FIGURE 4 RMS deviation for all atoms of HIV-1 IN derived from the
average structures during 1 ns of simulation shown as 10-ps averages.
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metal. The RMSD with respect to the average structure after
400 ps was maintained between 0.07 and 0.12 nm. The
analyses of atomic fluctuations indicate that the same re-
gions (141–148 and 190–192) showed the most flexibility
in the two simulations.
Flexibility, helix formation, and
coil-sheet transition
No metal in active site
Essential dynamics (ED) analysis techniques (Amadei et al.,
1993; van Alten et al., 1997) were applied, using the What
If program (Vriend, 1990), to our 1-ns trajectories in order
to identify the regions of the protein that exhibit the largest
flexibility during the simulations. This technique can be
used to filter out local vibrational motions across an MD
trajectory from the correlated ones. From our MD trajecto-
ries, a covariance matrix was built for the entire catalytic
domain, and diagonalized to identify the 10 most significant
motions of the solute along their eigenvectors (Fig. 6). Upon
examination of the probability distribution of the displace-
ments, for these projections, it was noted that the first two
modes did not fit a Gaussian distribution (Fig. 6). This
indicates a high anharmonicity and flexibility along these
modes. The largest contributions to eigenvector 1 are lo-
cated in the region 190–192, while the contributions to
eigenvector 2 come primarily from residues 141–148 (Fig.
6). These results were expected because these regions are
either missing or have high B-factors in the previously
determined structures (Dyda et al., 1994; Bujacz et al.,
1996a). Therefore, it should be noted in Fig. 6 that the large
contribution of region 190–192, and its neighborhood, to
the eigenvectors with eigenvalues indicate that it is very
flexible.
A detailed analysis of the time-dependent secondary
structural changes using the DSSP program (Kabsh and
Sander, 1983) revealed that a portion of our modeled loop
adopted a helical conformation, thus extending the 	-4 helix
(involving residues Q146–G149). This extension represents
one additional turn of the helix. It was also observed that
G149 assumed a helical conformation during the equilibra-
tion. The formation of this extra turn in the 	-helix occurs
during the first 300 ps of the simulation and then becomes
stable after 500 ps. This finding is not in agreement with
the experimental HIV-1 integrase crystal structure 2ITG
(Bujacz et al., 1996a), where an extended loop is found from
G141 up to S153.
The second missing region (190–192) and its neighbor-
hood have high flexibility, as mentioned above; however,
our secondary structure analysis shows a coil transition into
a small antiparallel 
-sheet. This behavior was observed in
both simulations, with and without metal, but this region
predominantly adopts a random coil conformation.
One metal in active site
The ED (Amadei et al., 1993; van Alten et al., 1997)
analysis for the system with one metal in the active site
yielded the same results concerning protein flexibility as for
the case with no metals; however, the secondary structure
analysis (DSSP) (Kabsh and Sander, 1983) of the modeled
region hints at some instability of the helical behavior for
the same region that became an extension (extra turn) of the
helix 	-4 in the system with no metal (Fig. 7). In this case,
the helix stretches during the dynamics simulation such that
an analysis with DSSP (Kabsh and Sander, 1983) in this
region reveals that these residues are less often in an ideal
helical range, being stable only from Q148.
The greater stabilization of this region in the system with
no metal ion is associated with a hydrogen-bonding inter-
action between the side chains of Q62 and Q148. This
interaction was observed to be due to a 1 torsional move-
ment of Q148, which is located at the start of the extra turn
of the helix in the no metal simulation. This result provides
some evidence that maintenance of a certain degree of
flexibility in this region (141–148) may be required for
FIGURE 5 Comparison between experimental B-factors (top graph) and
RMS fluctuations for C	 atoms (bottom graph) in HIV-1 IN. Note the two
empty regions in the top graph, which represent the two missing regions in
the crystal structure (141–148 and 190–192).
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enzymatic activity. However, the presence of one metal ion
reduces the amplitude of some of the protein’s vibrational
motions. The minima and maxima of the three eigenvalues
from the ED analyses for both systems are shown in Fig. 8,
showing the amplitudes of those flexibilities. Arrows high-
light the region 141–148, which is clearly more stable for
the one-metal simulation (arrow b).
Active site conformation
There are two factors accounting for the stabilization of the
helix in the absence of a metal ion: a hydrogen bond
between the side chains of Q62 and Q148 and a solvent
bridge between the hydroxyl of Y143 and a carboxylate
oxygen of E152. The interaction of Q62 with Q148, which
FIGURE 6 Displacements for the
10 highest eigenvectors (top set) and
their corresponding atomic fluctua-
tions throughout the 1 ns of MD for
the no-metal simulation (bottom set).
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is located at the start of the extra turn of the helix, anchors
the helix to other residues in the active site. Over the second
half of the simulation, when the helix is most stable, Y143
and E152 are almost continually bridged by one or two
water molecules, as can be seen in Fig. 9. This interaction
reduces the strain from the flexible loop adjacent to the
helix. Perhaps the most interesting role of the water in the
active site is the interaction between Q148 and the three
essential residues (D64, D116, and E152). Q148 usually
participates in three single-solvent-bridged interactions to
those key residues (Fig. 9). D64 and D116 are often bridged
by two water molecules, and E152 and D116 are occasion-
ally linked in the same fashion.
There is a marked difference in the water structure ob-
served in the active site during the one-metal simulation
(Fig. 10). First, it should be noted that the magnesium ion is
always complexed in an octahedral fashion by D64, D116,
and four water molecules. The average distance between the
magnesium ion and the oxygens of the coordinating water
molecules is 0.208 nm. Adding 0.14 nm for the radius of a
water molecule, the radius for the solvated magnesium ion
is just under 0.35 nm. It is interesting that most of the steric
conflicts that arise from the accommodation of the ion are
borne by the water and the side chains of Q148 and Y143.
Q148 can no longer occupy the center of the active site with
a hydrogen bond to Q62 and water-mediated interactions
with D64, D116, and E152. Instead, it is pushed back
toward the helix and interacts with E152, D116, and the
metal ion through three two-water solvent bridges. Y143
can no longer interact with E152, as Q148 now occupies its
previous position. The addition of the ion appears to make
the active site more hydrophilic, as there are fewer residue-
FIGURE 8 Superposition of HIV-1 IN structures containing the three highest eigenvectors over the three lowest ones for the no-metal (left) and one-metal
(right) simulations. Arrows a) and b) highlight the region 141–148, which is missing in the crystal structure.
FIGURE 7 Time-dependent secondary structure analyses for the helix
	-4 for the no-metal (top graph) and one-metal (bottom graph) simula-
tions. The analyses were carried out for the entire 1-ns simulations using
10-ps snapshots. Each symbol represents a residue considered to be helical.
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residue contacts and longer solvent-bridged contacts. The
displacement of Q148 by the hydrated magnesium ion
forces a change in orientation of Y143 and a destabilization
of the helix through the loss of favorable interactions for
both Q148 and Y143.
Distance measurements between the C of D64 and D116
reveal that the separation between the side chains of these
two residues is fairly stable across the MD simulations,
0.7–0.8 nm most of the time; however, distances involv-
ing those residues and the C of E152 show large fluctua-
tions in the no-metal case. These fluctuations are due to the
existence of two conformational preferences for the 1
angle of E152 at60 and180/180°. Distance fluctuations
are smaller when the magnesium ion is present in the active
site. Complexation of the Mg2 by D64 and D116 causes 1
of D116 to have only one conformational preference after
the system properties equilibration (see Fig. 11).
The third catalytic residue in the HIV-1 integrase active
site, E152, is missing in the 1ITG crystal structure but is
present in 2ITG with very high B-factors. Even though our
initial crystal structure has a part of this residue (up to C
)
and lacks Mg2, it still has high B-factors. The equivalent
catalytic residue in ASV IN (E157) also has substantial
flexibility and the distances to the other two catalytic resi-
dues (D64 and D121) are quite variable and seem to be
dependent on the presence or absence of divalent metals in
the active site. Distance measurements between the car-
boxyl groups of the catalytic residues of the three ASV IN
structures with no metals, as well as for our average struc-
tures of HIV-1 IN with no metals in the active site, are
shown in Table 1. Table 2 shows the distance measurements
for the HIV-1 IN average structure with one metal, in
addition to the three published ASV IN structures contain-
ing one divalent ion, all in the same metal-binding site.
According to our studies, the HIV-1 IN active site is some-
what wider than in the ASV IN with respect to the distances
among the catalytic residues, largely due to the flexibility of
E152, and the binding of Mg2 does not produce significant
conformational changes in the active site. These dimensions
are probably sensitive to the presence of a metal in the
second site which has been proposed to coordinate to the
third catalytic residue, E152, as in the ASV IN structures
containing two metals.
Another parameter studied was the angle formed among
the carboxyl groups of the catalytic residues. For both
systems studied, this angle converged after 500 ps to similar
values, but the fluctuations are visibly smaller for the sys-
tem with one metal ion in the active site (Fig. 12). This is
rather surprising considering the differences seen in Figs. 9
and 10, and it may imply a functional role.
FIGURE 9 Representation of protein-protein and protein-solvent inter-
actions seen in the active site. The only water molecules displayed are
involved in bridging contacts between side chains. The hydrogen bond
between D64 and the protein backbone is also shown on the right. The
backbone of the helix and flexible loop runs from the top to the left corner.
FIGURE 10 The active site in the presence of a divalent cation. Note the
octahedral coordination of the ion and the increased number of water
molecules as compared with the no-metal simulation in Fig. 9. Although
D64 is no longer able to form a hydrogen bond to the backbone, D116 has
gained an occasional solvent-mediated interaction to the flexible loop.
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Other important residues
We stress that Y143 has been pointed out as an important
residue in the catalytic process. Experimental observations
reveal a conserved tyrosine residue in the catalytic domain
close to the active site among a variety of retroviral inte-
grases (Engelman and Cragie, 1992). However, statistical
analyses show that tyrosines are rarely located in surface
loops, ranking as only 16th most often found residue in this
kind of secondary structure element (Kwasigroch et al.,
1996). Mutagenesis studies have shown that in the HIV-2
integrase catalytic core domain, replacement of this tyrosine
by a leucine does not reduce the enzymatic activity; how-
ever, it shifts the favored nucleophile for terminal cleavage
when Mn2 is present (i.e., it affects the balance between
hydrolysis/3-processing, and alcoholysis/strand transfer)
(van Gent et al., 1993; van den Ent et al., 1998). By using
the photo-cross-linking technique, the region between resi-
dues 139–152 was identified as the one interacting with
DNA (Heuer and Brown, 1997). These facts, taken together,
constitute convincing evidence that Y143 seems to play the
secondary role of stabilizing and directing the nucleophile
for most efficient and balanced catalysis, similar to that
proposed for DNA polymerase I (Beese and Steitz, 1991).
The sequence comparison between the first missing region
(141–148) in HIV-1 integrase and its corresponding region
in ASV integrase is shown below:
140	GIPYNPQSQGVVES153	: HIV-1 Integrase
145	GIPGNSQGQAMVER158	: ASV Integrase
In ASV, a glycine residue takes the place of the tyrosine
(Y143) in the HIV-1 integrase sequence. However, when
the heavy atoms of the catalytic triad (D64, D116, and
E152) in the average structure from the no-metal simulation
were superimposed on the equivalent residues in the ASV
integrase (D64, D121, and E157), it revealed that the hy-
droxyl group of Y143 in HIV-1 integrase was found struc-
turally close to the amide oxygen of residue Q151 in ASV
IN. Note also that the values for the angles involving the
carboxyl groups of the last two catalytic residues and the
hydroxyl group of Y143 in HIV-1 IN and the amide one in
ASV IN are similar, 74.2° and 78.1°, respectively. This
angle was found to be relatively constant during our simu-
lations in both cases despite the different orientation of
TABLE 1 Distances between carboxyl groups (nm) of the
catalytic triad D,D,35E motif in three ASV integrases and in
the HIV-1 integrase average structure for the no-metal
simulation
Residues HIV-1 IN (no metal) 1ASV 1ASW 1VSE
D64–D116 0.513 0.553 0.567 0.544
D116–E152 0.894 1.183 0.854 0.899
D64–E152 1.051 0.900 0.612 0.698
TABLE 2 Distances between carboxyl groups (nm) of the
catalytic triad D,D,35E motif in three ASV integrases and in
the HIV-1 integrase average structure for the one-metal
simulation
Residues HIV-1 IN (one metal) 1VSI 1VSF 1VSD
D64–D116 0.485 0.544 0.512 0.487
D116–E152 1.055 0.899 0.907 0.840
D64–E152 1.055 0.698 0.740 0.671
FIGURE 11 Distances between carboxyl groups
of the catalytic triad (top graphs) throughout the
simulations are shown along with the 1 dihedral
angle of D116 (bottom graphs) for the no-metal
(left) and one-metal (right) simulations. The thin
solid line represents the D64–D116 distance, the
dotted line D116–E152, and the thick line the dis-
tance between D64 and E152. All plots are shown as
10-ps averages.
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Y143 (with and without metal in the active site; see Fig. 13).
Again, the variation in the no-metal case is larger than when
one metal is present. This behavior shows the existence of
a spatial relationship between Y143 and the active site. This
part of the molecule (residues 141–148) constitutes an im-
portant region for the enzymatic mechanism and its behav-
ior could point to the need for flexibility for efficient cata-
lytic activity.
In addition to Y143, residues Q148 and N117, among
others, were also highlighted as critical residues for the
catalytic activity of the HIV-2 integrase in the work of Vink
and coworkers (Vink et al., 1993). Some of the conforma-
tional changes of Q148 in the absence of metals observed in
our simulation have already been discussed. The distance
between the C atoms of Q62 and Q148 plotted against the
distance between the C atoms of D64 and D116 shows a
significant correlation among these four residues for the
system with no metal (Fig. 14). This indicates that the
interaction between Q62 and Q148 is possible only if D116
assumes a different conformation.
Another important residue for normal enzymatic activity
is N117, which is located very close to the active site, but its
side chain is not pointed in that direction. The one-metal
simulation showed this residue to be rather stable as com-
pared with the crystal structure; however, in the no-metal
MD simulation, the 1 of N117 distorts in the direction of
the active site (Fig. 15).
CONCLUSIONS
MD simulations of the HIV-1 integrase containing no metal
or one metal in the active site were successfully carried out,
resulting in well-equilibrated molecular systems. Analyses
of time-dependent properties showed that the motions in
regions 141–148 and 190–192 have large amplitudes,
which agrees very well with the experimental difficulty in
determining the structures of these regions via x-ray crys-
tallography. Except for those regions, the whole protein was
found to be very stable.
Conformational flexibility of the secondary structure in
the region 146–149, between the system containing no
metal or one metal in the active site, implies some impor-
tance for flexibility in this region, which could be a require-
ment for efficient biological activity. This notion is further
supported by a recent result, in which two mutations
(G140A and G149A) introduced near this region rigidly
extended the helical conformation toward the N-terminal
side of 	-4 up to P145, which resulted in a significant
decrease in its catalytic activity (Greenwald et al., 1999,
personal communication). The active site of the HIV-1
FIGURE 12 Time-dependent variation of the angle formed between the
carboxyl group of the catalytic residues shown as 10-ps averages for the
no-metal (dotted line) and one-metal (solid line) simulations.
FIGURE 13 Angle formed by the hydroxyl oxygen of Y143 and the
carboxyl groups of the last two catalytic residues (D116 and E152) shown
as 10-ps averages for the no-metal (dotted line) and one-metal (solid line)
simulations.
FIGURE 14 Correlation of the distances between the C of Q62–Q148
and C between D64 and D116 shown as 10-ps averages from the no-metal
simulation.
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integrase has defined angular dimensions; however, pair-
wise distances were shown to be metal-dependent.
Residues Y143, Q148, and N117 and D116 showed sig-
nificant conformational changes with respect to the initial
structure only for the simulation with no metal, which
means that the presence of metals close to the active site
stabilizes this region as well as the loop formed between
141 and 145. Therefore, the absence of metal produces
a stabilization of the region 146–149 into an 	-helical
conformation.
Just before submission of this manuscript, two experi-
mental studies describing new HIV-1 IN crystal structures
without and with one magnesium ion in the active site was
published (Goldgur et al., 1998; Maignan et al., 1998). Our
findings such as the absence of large changes in the active
site upon binding the first magnesium ion, the position of
E152 being closer to D64 and D116 in the active site, an
extended 	-4 helix and its metal-dependent stability and
coil-sheet transitions in the neighborhood of the second
missing region, are all in very good agreement with this new
experimental paper (Goldgur et al., 1998; Maignan et al.,
1998). This shows the predictive capability of MD simula-
tions. It should also be noted that a preliminary report of
molecular dynamics simulations that qualitatively demon-
strated some of these structural features was presented prior
to publication of the experimental results (Nicklaus et al.,
1995).
The present study provides insights into the dynamics of
the HIV-1 IN and the importance of the first metal ion in the
active site, which can be useful for future studies involving
rational drug design. Simulations involving two magnesium
ions (ASV IN alignment-based) are underway. The results
of that simulation can help to more completely characterize
the HIV-1 IN active site conformation and address ques-
tions about the stability of the magnesium in the second
metal site.
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